<DOC>
	<DOCNO>NCT01112449</DOCNO>
	<brief_summary>Penn State Milton S. Hershey Medical Center researcher try compare effect two different form selenium ( selenium yeast selenomethionine ) blood selenium level biomarkers oxidative stress primary endpoint . One six men risk get prostate cancer lifetime . Participants ask take over-the-counter selenium yeast supplement selenomethionine placebo nine twelve month .</brief_summary>
	<brief_title>Influence Selenium Prostate Cancer Related Biomarkers</brief_title>
	<detailed_description>We conduct double-blind , randomize , placebo-controlled clinical study selenium supplementation form L-selenomethionine ( SM ) ( 200 µg/day ) selenium-enriched yeast ( SY ) ( 200 µg/day 285 µg/day ) 9 month ; 285 µg/day SY select deliver equivalent selenium 200 µg/day SM healthy men . The variability SM SY use less 3 % account 70.5 % SM content SY . As primary endpoint , determine effect two form selenium plasma level selenium metabolites well biomarkers oxidative stress several time point . As secondary endpoint , effect two form selenium plasma PSA level examine .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<criteria>No history evidence diabetes Male age 2079 PSA level ≤ 4.0 ng/mL Not take &gt; 50 µg/day selenium dietary supplement include multi vitamin Nonsmoker No concurrently participate participate clinical trial within least 30 day registration Health male Evidence prostate cancer Evidence liver kidney disease</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>selenium</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>prostate cancer</keyword>
	<keyword>PSA</keyword>
	<keyword>glucose</keyword>
</DOC>